Parnax Lab

Parnax Lab Tax Expense

The Income Tax Expense of Parnax Lab (506128.BO) as of Nov 14, 2026 is 41.35 M INR. In the previous year, Income Tax Expense was 24.25 M INR — a change of 70.52% (higher).

Tax Expense

41.35 MINR

YoY

70.52%

Last updated:

Income Tax Expense of Parnax Lab is 2025 41.35 M INR. Income Tax Expense of Parnax Lab was 2024 24.25 M INR. It decreases by 70.52% higher compared to the previous year.

The Parnax Lab Tax Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tax Expense
Date
Tax Expense
Jan 1, 2018
19.66 M INR
Jan 1, 2019
13.15 M INR
Jan 1, 2020
9.49 M INR
Jan 1, 2021
2.79 M INR
Jan 1, 2022
40.06 M INR
Jan 1, 2023
36.47 M INR
Jan 1, 2024
24.25 M INR
Jan 1, 2025
41.35 M INR
The Parnax Lab Tax Expense history
YEARTax ExpenseYoY
41.35 MINR+70.52%
24.25 MINR-33.50%
36.47 MINR-8.97%
40.06 MINR+1,337.43%
2.79 MINR-70.63%
9.49 MINR-27.82%
13.15 MINR-33.14%
19.66 MINR+92.85%
10.19 MINR+4.67%
9.74 MINR-17.76%
11.84 MINR+29.53%
9.14 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

Income Tax Expense of Parnax Lab is 41.35 M INR in 2025.

Income Tax Expense of Parnax Lab changed from 24.25 M INR to 41.35 M INR, representing a 70.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Income Tax Expense Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

Tax expense represents the total income taxes owed. It reflects the company's tax obligations and effective tax rate.

Income Tax Expense's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Income Tax Expense's Parnax Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Parnax Lab

All Key Metrics — Parnax Lab